Nanobiotix (NBTX) Assets Average (2019 - 2025)

Nanobiotix's Assets Average history runs 7 years deep, the most recent figure standing at $65.0 million for Q4 2025.

• On a quarterly basis, Assets Average fell 21.39% year-over-year to $65.0 million in Q4 2025; TTM through Dec 2025 was $65.0 million, a 21.39% decrease from a year earlier, with the FY2025 full-year figure at $74.3 million, down 14.14% from the prior year.
• Assets Average rose to $65.0 million in Q4 2025 per NBTX's latest filing, from $61.6 million in the prior quarter.
• Across five years, Assets Average topped out at $154.5 million in Q2 2021 and bottomed at $52.5 million in Q2 2023.
• The 5-year median for Assets Average is $78.1 million (2024), against an average of $89.4 million.
• Across the five-year window, Assets Average sank 48.15% in 2023 and surged 85.15% in 2024, its largest moves.
• Year by year, Assets Average stood at $132.8 million in 2021, then slumped by 44.66% to $73.5 million in 2022, then fell by 1.35% to $72.5 million in 2023, then grew by 14.04% to $82.7 million in 2024, then slipped by 21.39% to $65.0 million in 2025.
• Per Business Quant, the three latest NBTX Assets Average figures stand at $65.0 million (Q4 2025), $61.6 million (Q2 2025), and $82.7 million (Q4 2024).